Goswami, Pulak
Adeniran, Oladapo R.
K. Frantz, Shelby
Matsuoka, Lea
Du, Liping
Gandhi, Ripal T.
Collins, Zachary S.
Matrana, Marc R.
Petroziello, Michael
Brower, Jayson S.
Sze, Daniel Y.
Kennedy, Andrew S.
Golzarian, Jafar
Wang, Eric A.
Brown, Daniel B.
Article History
Received: 26 March 2022
Accepted: 4 October 2022
First Online: 17 November 2022
Declarations
:
: This study protocol was approved and reviewed by the Vanderbilt Ingram Cancer Center and Vanderbilt University Institutional Review Board (IRB) as GI 1523 (IRB number 150407) and subsequently approved at the other sites.All patients signed informed consent to participate. This study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: Ripal T. Gandhi is a consultant and speaker for Sirtex Medical and serves as a proctor for Sirtex Medical. Zachary S. Collins has received an institutional research grant from Sirtex Medical and serves as a speaker and consultant for Sirtex Medical. Jayson S. Brower is a consultant for Sirtex Medical. Daniel Y. Sze has received institutional research grants from Sirtex Medical and Boston Scientific. He was a consultant and has received support for travel/hotel/meals for meetings with Sirtex Medical and Boston Scientific. Andrew S. Kennedy has received institutional support from Sirtex Medical. Jafar Golzarian is a consultant for Sirtex Medical and Boston Scientific. He has also received institutional grant support from Sirtex Medical. Eric A. Wang is a proctor for Sirtex Medical. Daniel B. Brown has received institutional research support from Sirtex Medical and Guerbet. He has served as a speaker for Cook Medical and a Data Safety Monitor for Bard Medical. The other authors do not have a conflict to report.